Aclaris Therapeutics Inc — Balance Sheet (NASDAQ:ACRS) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 70.78 M251.21 M254.6 M197.41 M220.33 M160.46 M Total liabilities 33.13 M53.87 M56.98 M40.23 M64.77 M57.38 M Total equity 37.65 M197.34 M197.62 M157.18 M155.55 M103.08 M Total liabilities & shareholders' equities 70.78 M251.21 M254.6 M197.41 M220.33 M160.46 M Total debt —————— Net debt ——————

新闻

Stifel因管线前景上调Aclaris Therapeutics目标价至3美元

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris TherapeuticsQ4每股收益及营收逊于预期

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris启动ATI-052治疗哮喘患者的1b期试验

Aclaris starts phase 1b trial of ATI-052 in asthma patients

Craig-Hallum 以"买入"评级开始对 Aclaris Therapeutics 股票的覆盖

Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating

Aclaris stock gets Buy rating reaffirmed by H.C. Wainwright after positive preclinical results